[ARWR] YoY Quarter Result on 30-Sep-2013 [#Q4]

Stock
[ARWR] Arrowhead Pharmaceuticals, Inc.
Announcement Date
18-Dec-2013
Financial Year
2013
Quarter
30-Sep-2013 [#Q4]
Profit Trend
QoQ- -125.23%
YoY- -157.66%
Quarter Report
ARWR's Result
ARWR's Financial Summary
View:
Show?
Quarter Result
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Revenue 31 44 44 44 44 290,848 181 -25.45%
PBT -22,220 -24,741 -22,425 -13,805 -5,601 -2,947 -6,957,038 -61.59%
Tax 2 2 5 354 -22,110,563 -14,078,360 -3,770 -
NP -22,222 -24,743 -22,430 -13,692 -5,314 -2,777 -2,004 49.27%
Tax Rate - - - - - - - -
Total Cost 22,253 24,787 22,474 13,736 5,357 293,624 2,185 47.17%
Ratio Analysis
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
NP Margin -71,110.36 -56,555.74 -51,269.58 -31,296.42 -12,145.56 -0.95 -1,109.12 99.93%
Per Share
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
EPS -0.31 -0.42 -0.42 -0.36 -0.38 -0.27 -0.28 1.70%
EPS Diluted -0.31 -0.42 -0.41 -0.36 -0.38 -0.27 -0.28 1.70%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.